<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">91291</article-id><article-id pub-id-type="doi">10.7554/eLife.91291</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Differential interaction patterns of opioid analgesics with µ opioid receptors correlate with ligand-specific voltage sensitivity</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-305478"><name><surname>Kirchhofer</surname><given-names>Sina B</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6285-9054</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262734"><name><surname>Lim</surname><given-names>Victor Jun Yu</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-343166"><name><surname>Ernst</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-329036"><name><surname>Karsai</surname><given-names>Noemi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0000-3948-4071</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-262733"><name><surname>Julia</surname><given-names>Ruland G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-230968"><name><surname>Canals</surname><given-names>Meritxell</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-167350"><name><surname>Kolb</surname><given-names>Peter</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4089-614X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-77463"><name><surname>Bünemann</surname><given-names>Moritz</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2259-4378</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pharmacology and Clinical Pharmacy</institution>, <institution>Philipp University of Marburg</institution>, <addr-line><named-content content-type="city">Marburg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><institution content-type="dept">Department of Pharmaceutical Chemistry</institution>, <institution>Philipp University of Marburg</institution>, <addr-line><named-content content-type="city">Marburg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff3"><institution content-type="dept">Division of Physiology, Pharmacology and Neuroscience</institution>, <institution>University of Nottingham</institution>, <addr-line><named-content content-type="city">Nottingham</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5115"><name><surname>Swartz</surname><given-names>Kenton J</given-names></name><role>Reviewing editor</role><aff><institution>National Institute of Neurological Disorders and Stroke, National Institutes of Health</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>peter.kolb@uni-marburg.de</email> (PK);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>Moritz.buenemann@staff.uni-marburg.de</email> (MB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>11</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e91291</elocation-id><history><date date-type="received"><day>25</day><month>07</month><year>2023</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Kirchhofer et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Kirchhofer et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-91291-v1.pdf"/><abstract><p>The µ opioid receptor (MOR) is the key target for analgesia, but the application of opioids is accompanied by several issues. There is a wide range of opioid analgesics, differing in their chemical structure and their properties of receptor activation and subsequent effects. A better understanding of ligand-receptor interactions and the resulting effects is important. Here, we calculated the respective binding poses for several opioids and analyzed interaction fingerprints between ligand and receptor. We further corroborated the interactions experimentally by cellular assays. As MOR was observed to display ligand-induced modulation of activity due to changes in membrane potential, we further analyzed the effects of voltage sensitivity on this receptor. Combining <italic>in silico</italic> and <italic>in vitro</italic> approaches, we defined discriminating interaction patterns responsible for ligand-specific voltage sensitivity and present new insights into their specific effects on activation of the MOR.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id><institution>European Commission</institution></institution-wrap></funding-source><award-id>H2020-MSCA- 860229</award-id><principal-award-recipient><name><surname>Canals</surname><given-names>Meritxell</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>United Kingdom Academy of Medical Siences Proffessorship</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Canals</surname><given-names>Meritxell</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1, 3, 4, 5, 6.</p></sec><supplementary-material><ext-link xlink:href="elife-91291-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>